<DOC>
	<DOCNO>NCT00783198</DOCNO>
	<brief_summary>This study evaluate efficacy safety ragweed sublingual tablet ( SCH 39641/MK-3641 ) compare placebo participant ragweed-induced rhinoconjunctivitis one-year period . It expect ragweed allergic participant one active arm trial decrease allergic rhinoconjunctivitis symptom require less allergy rescue medication ragweed pollen season .</brief_summary>
	<brief_title>Efficacy Long-Term Safety Ragweed ( Ambrosia Artemisiifolia ) Sublingual Tablet Adults With History Ragweed-Induced Rhinoconjunctivitis With Without Asthma ( Study P05233 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<criteria>Must clinical history significant ragweedinduced allergic rhinoconjunctivitis least 2 year duration , without asthma receive treatment previous RS . Must positive skin prick test response Ambrosia artemisiifolia Screening Visit . Must positive specific immunoglobulin E ( IgE ) Ambrosia artemisiifolia Screening Visit . Must force expiratory volume 1 second ( FEV1 ) least 70 % predict Screening Visit . Safety laboratory test vital sign conduct Screening Visit must within normal limit clinically acceptable investigator/sponsor Clinical history symptomatic seasonal allergic rhinitis and/or asthma receive regular medication , due another allergen potentially overlap RS . Clinical history significant symptomatic perennial allergic rhinitis and/or asthma due allergen participant regularly expose . Receipt immunosuppressive treatment within 3 month prior Screening Visit ( except steroid allergic asthma symptom ) . Clinical history severe asthma . Asthma require medium high dose inhale corticosteroid . History anaphylaxis cardiorespiratory symptom . History chronic urticaria angioedema . Clinical history chronic sinusitis 2 year prior Screening Visit . Current severe atopic dermatitis . Breastfeeding , pregnant , intend become pregnant . Had previous treatment immunotherapy ragweed allergen allergen 5 year prior Screening Visit . History allergy , hypersensitivity intolerance ingredient investigational medicinal product ( except Ambrosia artemisiifolia ) , rescue medication , selfinjectable epinephrine . History selfinjectable epinephrine use .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>